Last reviewed · How we verify
CRN09682
At a glance
| Generic name | CRN09682 |
|---|---|
| Sponsor | Crinetics Pharmaceuticals Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- CRN09682 CI brief — competitive landscape report
- CRN09682 updates RSS · CI watch RSS
- Crinetics Pharmaceuticals Inc. portfolio CI